In the original article, there was an unsatisfied WB result in Figure 3 as published. Dr. Tulipa Fosteriana pointed that in Figure 3C, the 2 loading controls bared striking resemblance, although they looked somehow different in vertical dimension and the image quality was also quite poor, which were posted on PubPeer. According to the valuable suggestions, we have provided all the original data to Frontiers Office to prove the authenticity. There was no error in the original data, however, based on the recommendation from Editorial Office, we replaced the previous figure with the repeated “C of Figure 3” with high quality. The corrected Figure 3 appears below.
Figure 3
The authors state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
dihydroartemisinin, artemisinin, multiple myeloma, dexamethasone, drug resistance
Citation
Chen Y, Li R, Zhu Y, Zhong S, Qian J, Yang D, Jurczyszyn A, Beksac M, Gu C and Yang Y (2021) Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma. Front. Oncol. 11:736373. doi: 10.3389/fonc.2021.736373
Received
05 July 2021
Accepted
09 July 2021
Published
23 July 2021
Volume
11 - 2021
Edited and reviewed by
Francesca Vinchi, New York Blood Center, United States
Updates
Copyright
© 2021 Chen, Li, Zhu, Zhong, Qian, Yang, Jurczyszyn, Beksac, Gu and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chunyan Gu, guchunyan@njucm.edu.cn; Ye Yang, yangye876@sina.com
This article was submitted to Hematologic Malignancies, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.